North America holds a substantial share of the Cancer Tissue Diagnostics Market, driven by its highly developed healthcare infrastructure, strong research capabilities, and increasing focus on precision oncology. The region is witnessing growing adoption of advanced diagnostic technologies, including molecular pathology, digital pathology, immunohistochemistry, and biomarker testing solutions....